{"database": "lobbying", "table": "lobbying_activities", "rows": [[2340795, "731c97b8-97d4-410d-be26-af20a7fd9401", "Q3", "IPOLICY SOLUTIONS", 401105127, "INVITAE INC.", 2019, "third_quarter", "MMM", "Medicare coverage of next generation sequencing based tests for cancer\nH.R.4393 - Advancing Access to Precision Medicine Act", "HOUSE OF REPRESENTATIVES,SENATE", 58000, null, 0, 0, "2019-10-11T15:12:33.817000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2340795"], "units": {}, "query_ms": 0.5186229827813804, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}